Atara Biotherapeutics, Inc. Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Atara Biotherapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • Atara Biotherapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 202 %.
  • Atara Biotherapeutics, Inc. annual Return On Equity for 2023 was 1.42K %.
  • Atara Biotherapeutics, Inc. annual Return On Equity for 2022 was -115 %, a 11.4% decline from 2021.
  • Atara Biotherapeutics, Inc. annual Return On Equity for 2021 was -103 %, a 21.9% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 1.42K +1.54K Jan 1, 2023 Dec 31, 2023
2022 -115 -11.7 -11.4% Jan 1, 2022 Dec 31, 2022
2021 -103 -18.5 -21.9% Jan 1, 2021 Dec 31, 2021
2020 -84.6 +18.9 +18.2% Jan 1, 2020 Dec 31, 2020
2019 -103 -46.9 -83.1% Jan 1, 2019 Dec 31, 2019
2018 -56.5 +0.55 +0.96% Jan 1, 2018 Dec 31, 2018
2017 -57 -28.8 -102% Jan 1, 2017 Dec 31, 2017
2016 -28.3 -4.54 -19.1% Jan 1, 2016 Dec 31, 2016
2015 -23.7 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.